Peripheral blood MRGPRX2 protein as a biomarker for the diagnosis of perioperative drug anaphylaxis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300077364

Enrollment

Unknown

Registered

2023-11-06

Start date

2023-11-12

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic people

Interventions

Patients with allergic reactions:NONE

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients greater than or equal to 18 years of age, and less than or equal to 65 years of age, male or female patients undergoing elective surgery for the first time, and patients with anaphylaxis after medication.

Exclusion criteria

Exclusion criteria: (1) Patients with malignant tumors; (2) those who are pregnant or breastfeeding; (3) have other serious liver, kidney, heart, hematopoietic, nervous system or mental disorders; (4) Other conditions deemed unsuitable for inclusion by the researcher.

Design outcomes

Primary

Measure	Time frame
MRGPRX2;	—

Secondary

Measure	Time frame
Blood routine;Percentage of basophils;	—

Countries

China

Contacts

Public ContactZijun Gao

Xi 'an Red Society Hospital

kobe84629@163.com+86 158 2974 0616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026